🍪 The GLP Lounge uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsInternationalSwitzerland BAG coverage — 12 month update Page 6

Switzerland BAG coverage — 12 month update

SarahChen_PharmD Mon, Feb 2, 2026 at 5:10 PM 29 replies 1,533 viewsPage 6 of 6
pam_stl
Member
267
1,123
Oct 2024
St. Louis, MO
Feb 5, 2026 at 11:38 AM#26

A narrower follow-up, since the general answer is now clear:

Did your prescriber agree with that reading, and if not what was their objection?

Last edited: Feb 5, 2026 at 4:38 PM
31 4Dr.ObesityMed, HealthEcon_DC, PedsEndoPhilly and 28 others
Reply Quote Save Share Report
raj_cambridge
Member
489
2,123
Jun 2024
Cambridge, MA
Feb 5, 2026 at 6:43 PM#27
dan_philly said:
If you are comparing against somebody else’s result, check that you are comparing the same measurement taken the same way.

Careful with the causal language. Two things moving together in a period when five things changed is not a mechanism, and stating it as one makes the thread less useful to somebody reading it later.

32 5DoseLogDan, SleepFixSam, PurityPaulOR and 29 others
Reply Quote Save Share Report
nick_SD_fit
Member
278
1,234
Sep 2024
San Diego, CA
Feb 6, 2026 at 1:48 AM#28
dan_philly said:
If you are comparing against somebody else’s result, check that you are comparing the same measurement taken the same way.

Agreed, and the size of the effect matters as much as its existence. Something real and small gets treated here as though it were real and decisive.

Correct me if the detail matters more than I have assumed.

33 6EndoResFellow, PharmacoVig_BOS, SurmountFan_IN and 30 others
Reply Quote Save Share Report

Sigma-Aldrich — Research-Grade Standards

Certified reference materials, analytical reagents, and research-grade standards for peptide verification. Trusted by laboratories worldwide.

Shop Reference Standards
Dr.PulmRoch
Member
456
2,345
Jun 2024
Rochester, MN
Feb 6, 2026 at 8:53 AM#29
dan_philly said:
If you are comparing against somebody else’s result, check that you are comparing the same measurement taken the same way.

That reframing is the part I needed.

Last edited: Feb 6, 2026 at 9:53 AM
34 7DebRD_ATL, KristenIndy, MarkLI_maint and 31 others
Reply Quote Save Share Report
SarahChen_PharmD
VIP Member
4,567
22,341
Dec 2023
San Diego, CA
Feb 6, 2026 at 3:58 PM#30

OP back with an update, since a thread like this is useless without one.

Follow-up — getting the denial reason in writing was the step that mattered. It named the criterion, and the criterion was a document I already had.

6 4robert_kc, dan_philly, MeganSA_TX and 3 others
Reply Quote Save Share Report
1456

Similar Threads

EU EMA compounding guidance — 2026 regulatory update9 replies
UK NHS GLP-1 prescribing — NICE TA875 and access guide7 replies
Australian TGA scheduling changes — peptide access 20268 replies
Canadian GLP-1 coverage — provincial formulary comparison6 replies
Purchasing GLP-1 in Mexico — legality, quality, and safety concerns6 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register